Astrana Health, Inc. ASTH NASDAQ

Astrana Health, Inc. (ASTH) generated $114.6M in operating cash flow for fiscal year 2025. After capital expenditures of $10.11M, free cash flow was $104.49M.

Free cash flow margin was 3.3% of revenue. Cash conversion ratio was 4.76x, indicating earnings are backed by cash.

The company returned $7.89M in dividends and $15.43M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (24/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (30/100) — Cash conversion ratio was 4.76x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 56/100 with 3/7 criteria passed.